SYDNEY, Sept. 11, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the HC Wainwright 23^rd Annual Global Investment Conference, to be held virtually from 13-15 September 2021.

The HC Wainwright Annual Global...